Curanex Pharmaceuticals (CURX) announced the appointment of two life sciences research experts to the Company’s Scientific Advisory Board. Daniel Pascheles is Former CEO and Partner at Molekule Consulting. Nicholas Meanwell spent four decades at Bristol Myers Squibb (BMY)
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CURX: